First, the fractional contribution of gut ammonia production, disturbed urea cycle function, glutamine synthetase expression or enhanced hepatic glutaminase activity contribution to altered ammonia and glutamine homeostasis in the context of Fatty Liver Disease remains to be addressed. This evidence concerns the gene GLS and fatty liver disease.